Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO3 pseudogene 2 (MTCO3P2) is a human pseudogene annotated as a non-functional genomic sequence with sequence similarity to the functional MT-CO3 gene, which encodes the mitochondrially encoded cytochrome c oxidase III protein—an essential component of complex IV in the mitochondrial respiratory chain. Pseudogenes, such as MTCO3P2, do not produce a functional protein product and are not considered therapeutic targets, nor are they involved in canonical biological, disease, or drug interaction pathways. The designation “pseudogene” indicates that while it shares sequence homology with a functional gene (in this case, the mitochondrial gene MT-CO3), it has lost the capacity for protein coding due to mutations or the absence of regulatory elements necessary for expression. MTCO3P2 should not be confused with MT-CO3, the coding gene for cytochrome c oxidase subunit III, mutations of which are associated with mitochondrial diseases such as Leigh syndrome and mitochondrial complex IV deficiency.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO3 pseudogene 2 (MTCO3P2).